Natural killer T cell activation inhibits hepatitis B virus replication in vivo

Journal of Experimental Medicine

Volumn 192, Issue 7, 2000, Pages 921-930

  Kakimi, Kazuhiro ^a   Guidotti, Luca G ^a   Koezuka, Yasuhiko ^b   Chisari, Francis V ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

Hepatitis B virus; Immunity; Liver; Natural killer T cells; Transgenic knockout

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; GALACTOSYLCERAMIDE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIVIRAL ACTIVITY; ARTICLE; CELL ACTIVATION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HEPATITIS B VIRUS; IMMUNE RESPONSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GALACTOSYLCERAMIDES; HEPATITIS B VIRUS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; TIME FACTORS; VIRUS REPLICATION;

EID: 0034596944     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.7.921     Document Type: Article

References (51)

1. - T cells in mice and humans
2. + cells in mouse liver
3. - single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family
4. + cells in the liver of mice
5. + cells: New clues to their origin, specificity, and function
6. Mouse CD1-specific NK1 T cells: Development, specificity, and function
7. + T cells
8. Mouse CD1 is mainly expressed on hemopoietic-derived cells
9. Lipid antigen presentation in the immune system: Lessons learned from CD1d knockout mice
10. Agelasphis, novel α-galactosylceramides from marine sponge Agelas mauritianus
11. Agelasphins, novel antitumor and immunostimulatory cerebrosides from marine sponge Agelas mauritianus
12. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides
13. + NK T lymphocytes
14. - restricted NK T cells
15. Cutting edge: Activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
16. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
17. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
18. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells
19. + effector function against intracellular infection
20. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
21. Murine natural killer T (NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls
22. Requirement for valpha14 NKT cells in IL-12-mediated rejection of tumors
23. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
24. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines
25. Nitric oxide inhibits hepatitis B virus replication in the liver of transgenic mice
26. Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver
27. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice
28. Viral clearance without destruction of infected cells during acute HBV infection
29. High-level hepatitis B virus replication in transgenic mice
30. Multiple defects of immune cell function in mice with disrupted interferon-γ genes
31. Functional role of type I and type II interferons in antiviral defense
32. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
33. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
34. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance
35. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views
36. The surface phenotype of dendritic cells purified from mouse thymus and spleen: Investigation of the CD8 expression by a subpopulation of dendritic cells
37. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule
38. Macrophages and inflammatory mediators in tissue injury
39. Identification of a monoclonal antibody specific for a murine T3 polypeptide
40. Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: A major role for bone marrow in NKT cell homeostasis
41. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove
42. + T cells
43. CD1-restricted T cell recognition of microbial lipoglycan antigens
44. Murine CD1d-restricted T cell recognition of cellular lipids
45. The molecular biology of the hepatitis B viruses
46. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
47. NK cell receptors
48. Hepatitis B virus immunopathogenesis
49. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice
50. + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns
51. Natural T cells in the human liver: Cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogeneous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells